期刊
BIOENGINEERED
卷 12, 期 1, 页码 6529-6537出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21655979.2021.1973876
关键词
Hepatocellular carcinoma; stk39; p38; proliferation; invasion
资金
- Deyang City Science and Technology Project [2018SZS077]
This study found that the expression of STK39 was enhanced in HCC patients and tissues, and knockdown of STK39 suppressed the proliferation, migration, and invasion of HCC cells by inducing lower levels of p-p38. Additionally, STK39 silencing reduced c-Myc levels in the cells, and inhibited HCC tumor growth in vivo.
Hepatocellular carcinoma (HCC) is a serious malignant tumor of the liver. It has been reported that serine/threonine kinase 39 (STK39) participates in tumorigenesis. However, the role of STK39 in HCC remains unknown. In this study, the qRT-PCR and western blot assay demonstrated that STK39 expression was enhanced in HCC patients and tissues. Moreover, CCK-8 and colony formation assays confirmed that knockdown of STK39 suppressed SK-HEP-1 and Huh7 cells proliferation. Furthermore, wound healing assay and transwell assay revealed that knockdown of STK39 repressed SK-HEP-1 and Huh7 cells migration and invasion. Interestingly, knockdown of STK39 reduced p-p38/p38 ratio and levels of c-Myc. Consistently, knockdown of STK39 inhibited the HCC tumor growth in vivo. In summary, knockdown of STK39 suppressed the proliferation, migration, and invasion of HCC cells by inducing the lower levels of p-p38, which might provide a novel therapeutic target for HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据